PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 27 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Oral administration of 10% ethanolic root extract inhibited carrageenan-induced rat paw edema and showed antipyretic effects in rats [PMID: 9690339]
Leaf extracts showed strong induction of wound closure in in vitro scratch tests on HaCaT keratinocytes [PMID: 35807516]. A topical ointment containing leaf extract and propolis showed improvement in rat skin ulcers compared to untreated lesions [PMID: 29877862]
Ostruthin demonstrated in vitro activity against rapidly growing Mycobacteria (e.g., M. smegmatis, M. abscessus) [PMID: 12709907, 34572657] and anti-staphylococcal activity against S. aureus [PMID: 37636068].
Ostruthin was identified as the major substance inhibiting serum-induced proliferation of rat aortic vascular smooth muscle cells [PMID: 21627108]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 12506234 (2003) — 8-(2-bromo-3-methoxy-3-methylbutyl)-7-methoxycoumarin. · Acta crystallographica. Section C, Crystal structure communications
- 2.PMID: 28513464 (2017) — Pharmacological features of osthole. · Postepy higieny i medycyny doswiadczalnej (Online)
- 3.PMID: 32825714 (2020) — Peucedanum ostruthium Inhibits E-Selectin and VCAM-1 Expression in Endothelial Cells through Interference with NF-κB Signaling. · Biomolecules
- 4.PMID: 34572657 (2021) — Efflux Pump Inhibition and Resistance Modulation in Mycobacterium smegmatis by Peucedanum ostruthium and Its Coumarins. · Antibiotics (Basel, Switzerland)
- 5.PMID: 26493217 (2015) — DNA-based identification of Peucedanum ostruthium specimens and detection of common adulterants by high-resolution melting curve analysis.